A Hydrogel as a Bespoke Delivery Platform for Stromal Cell-Derived Factor-1

Area of Science:

• Biomaterials Science
• Neuroscience
• Regenerative Medicine

Background:

• Self-assembled peptide hydrogels (SAPs) offer potential for traumatic brain injury (TBI) repair by creating a stable environment.
• Therapeutic proteins like stromal-derived factor 1 (SDF-1) can restore function but face challenges with rapid diffusion and degradation.
• Existing treatments for TBI often struggle with effective delivery and long-term support of therapeutic agents.

Purpose of the Study:

• To engineer a homeostatic hydrogel by incorporating recombinant SDF-1 into a SAP hydrogel.
• To create a supportive milieu for transplanted neural progenitor cells (NPCs).
• To evaluate the hydrogel's efficacy in delivering NPCs and sustained SDF-1 for neural repair.

Main Methods:

• Incorporation of recombinant SDF-1 protein into a self-assembled peptide hydrogel matrix.
• Co-delivery of viable primary neural progenitor cells and sustained active SDF-1.
• Assessment of graft survival, neuronal differentiation, and innervation in a neural injury model.

Main Results:

• The engineered hydrogel successfully delivered viable NPCs and sustained active SDF-1.
• Increased neuronal differentiation and a larger, healthier graft core were observed.
• Neuronal fiber growth and innervation were not impeded by the hydrogel.

Conclusions:

• Engineered homeostatic hydrogels show significant potential for treating neural injuries and diseases.
• This approach enhances the integration of grafted cells by providing sustained therapeutic support.
• SAPs offer a promising platform for developing advanced therapies for central nervous system repair.